Paul E. Freiman - May 21, 2022 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Director
Signature
/s/ Justin Hall as attorney in fact for Paul E. Freiman
Stock symbol
NBY
Transactions as of
May 21, 2022
Transactions value $
$0
Form type
4
Date filed
5/24/2022, 07:30 PM
Previous filing
May 13, 2022
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBY Common Stock Options Exercise +30K 30K May 21, 2022 Direct F1
holding NBY Common Stock 2.31K May 21, 2022 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBY Restricted Stock Units Options Exercise $0 -30K -50% $0.00 30K May 21, 2022 Common Stock 30K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.